top of page
Search

Resp: Obstructive Sleep Apnea & Obesity Hypoventilation for MRCP Part 1

TL;DR

Resp: Obstructive Sleep Apnea & Obesity Hypoventilation are high-yield topics in MRCP Part 1, especially for ABG interpretation, sleep physiology, and complications like pulmonary hypertension. OSA involves intermittent airway obstruction during sleep, whereas obesity hypoventilation syndrome (OHS) causes persistent daytime hypercapnia. The key exam distinction is normal vs elevated daytime CO₂, guiding management (CPAP vs NIV). Expect integrated MCQs combining obesity, hypoxia, and respiratory failure.


Why this matters

Sleep-disordered breathing is a recurring theme in MRCP Part 1 because it integrates respiratory physiology, cardiovascular complications, and metabolic risk factors. Questions commonly test pattern recognition, especially distinguishing OSA vs OHS, interpreting arterial blood gases, and selecting appropriate treatment.

Candidates are expected to:

  • Recognise clinical patterns quickly

  • Interpret ABGs accurately

  • Differentiate OSA from OHS

  • Identify complications and management strategies

For broader preparation, review the MRCP Part 1 overview.


Core sections

1. Obstructive Sleep Apnoea (OSA): Definition & Pathophysiology

OSA is characterised by recurrent upper airway collapse during sleep, resulting in apnoea (cessation of airflow) or hypopnoea (reduced airflow).

Pathophysiology highlights:

  • Reduced pharyngeal muscle tone during sleep

  • Obesity → fat deposition around airway

  • Increased airway resistance

Consequences:

  • Intermittent hypoxia

  • Sleep fragmentation

  • Sympathetic overactivity

2. Clinical Features (Exam Favourite)

Typical MRCP vignette:

  • Obese middle-aged male

  • Loud snoring

  • Witnessed apnoeas

  • Excessive daytime sleepiness

Additional features:

  • Morning headaches

  • Poor concentration

  • Erectile dysfunction

  • Resistant hypertension

3. Diagnosis of OSA

Gold standard: Polysomnography

Apnoea–Hypopnoea Index (AHI):

  • Mild: 5–15

  • Moderate: 15–30

  • Severe: >30

👉 Exam tip: Severity thresholds are frequently tested.

4. Management of OSA

First-line treatment:

  • Continuous Positive Airway Pressure (CPAP)

Adjunct measures:

  • Weight loss

  • Avoid alcohol and sedatives

  • Sleep position modification

High-yield fact: CPAP reduces cardiovascular risk and improves daytime alertness.

5. Obesity Hypoventilation Syndrome (OHS): Definition

OHS is defined by:

  • BMI ≥30 kg/m²

  • Daytime hypercapnia (PaCO₂ >6 kPa / 45 mmHg)

  • No alternative cause of hypoventilation

Core mechanism:

  • Impaired ventilatory drive + increased work of breathing

6. OSA vs OHS (High-Yield Comparison)

Feature

OSA

OHS

Hypoventilation

Sleep only

Day and night

Daytime CO₂

Normal

Elevated

Oxygen levels

Intermittent drops

Persistent hypoxia

ABG

Normal

Chronic respiratory acidosis

BMI

Often high

Always ≥30

Treatment

CPAP

NIV (BiPAP)

👉 Key exam trigger: Daytime hypercapnia = OHS

7. ABG Interpretation (Critical Topic)

In OHS:

  • ↑ PaCO₂

  • ↓ PaO₂

  • ↑ HCO₃⁻ (compensation)

Pattern: Chronic respiratory acidosis

8. Complications (Common MRCP Questions)

  • Pulmonary hypertension

  • Cor pulmonale (right heart failure)

  • Polycythaemia

  • Cardiovascular disease (MI, stroke)

👉 OHS carries higher mortality risk than OSA

9. Management of OHS

First-line:

  • Non-invasive ventilation (NIV / BiPAP)

Additional measures:

  • Weight reduction (definitive treatment)

  • Careful oxygen therapy

  • Treat coexisting OSA

10. High-Yield Summary Points

  1. OSA = intermittent airway collapse during sleep

  2. OHS = obesity + daytime hypercapnia

  3. ABG normal in OSA, abnormal in OHS

  4. CPAP = OSA treatment

  5. NIV = OHS treatment

  6. Both increase cardiovascular risk

  7. Polysomnography confirms diagnosis

  8. Weight loss is essential

  9. OHS has worse prognosis

  10. Daytime CO₂ is the key differentiator

MRCP Part 1 study setup with notes on obstructive sleep apnoea and obesity hypoventilation syndrome

Practical examples / mini-cases

MCQ:A 50-year-old obese man presents with daytime somnolence. ABG shows PaCO₂ 52 mmHg and HCO₃⁻ 30 mmol/L. What is the diagnosis?

A. Obstructive sleep apnoeaB. COPDC. Obesity hypoventilation syndromeD. AsthmaE. Pulmonary fibrosis

Answer: C. Obesity hypoventilation syndrome

Explanation: Daytime hypercapnia with metabolic compensation indicates chronic hypoventilation → classic OHS. OSA does not cause persistent daytime CO₂ retention.

Practise similar questions via Free MRCP MCQs or simulate exam conditions with Start a mock test.


Common pitfalls

  • Confusing OSA with OHS (check ABG)

  • Missing raised bicarbonate (chronic compensation)

  • Assuming all obese patients have OHS

  • Using CPAP instead of NIV in OHS

  • Ignoring cardiovascular complications


FAQs

1. What is the key difference between OSA and OHS?

OSA involves intermittent airway obstruction during sleep, while OHS causes persistent daytime hypercapnia due to hypoventilation.

2. What is the first-line treatment for OSA?

CPAP is the standard treatment and improves symptoms and cardiovascular outcomes.

3. Why is bicarbonate raised in OHS?

It reflects renal compensation for chronic respiratory acidosis due to CO₂ retention.

4. Can OSA cause pulmonary hypertension?

Yes, recurrent hypoxia leads to pulmonary vasoconstriction and eventual right heart strain.

5. When should NIV be used?

NIV is indicated in OHS with daytime hypercapnia, as ventilatory support is required.


Ready to start?

Strengthen your respiratory preparation for MRCP Part 1 with structured learning and active recall. Start with the MRCP Part 1 overview, practise regularly using Free MRCP MCQs, and reinforce weak areas through interactive lectures.


Sources

 
 
 

Comments

bottom of page